TrialThe lancet. HIV2024

HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study.

Deborah Persaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.